PHYTRIX AG has a total of 14 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Canada and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ISO ARZNEIMITTEL GMBH & CO KG, ZHUHAI SMILEBIOTEK CO LTD and STEM CELL PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Canada | 3 | |
#3 | Australia | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Unspecified technologies | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Wagner Hildebert | 6 |
#2 | Manns Michael P | 5 |
#3 | Ott Michael | 4 |
#4 | Lees Andrew | 4 |
#5 | Olanow Waren C | 3 |
#6 | Buchner Johannes | 2 |
#7 | Muschler Paul | 2 |
#8 | Bahr Matthias | 2 |
#9 | Gebhardt Rolf | 2 |
#10 | Halsbeck Martin | 2 |
Publication | Filing date | Title |
---|---|---|
CA2504201A1 | Mucuna pruriens and extracts thereof for the treatment of neurological diseases | |
EP1390481A2 | RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT) |